Skip to content Skip to sidebar Skip to footer

Newsletter

Charlie Youlden

Charlie is an Associate Equity Research Analyst covering ASX small caps across technology, mining and industrials.

His investing journey began in 2020 with large-cap US technology stocks, before he went on to complete a Commerce degree in Finance and Marketing at UTS, the Wall Street Prep Financial Modelling course, and Columbia Business School’s Value Investing course.

Charlie’s goal is to make investing clear, digestible and genuinely useful for everyday retail investors, helping them make better decisions with more confidence.

749 articles published

Mining Stocks

Jindalee Lithium (ASX: JLL) Surges 45% on US$500M SPAC Deal for McDermitt

Jindalee Lithium Unlocks US Market Path With SPAC Agreement Jindalee Lithium (ASX: JLL) just delivered one of the most eye-catching moves on the ASX, with shares surging 45 percent after a strategic update that could reshape its growth trajectory. The company has signed a non-binding Letter of Intent with Constellation Acquisition Corp, a US-based SPAC…

ByCharlie YouldenSeptember 9, 20250Comments

Healthcare Stocks Tech Stocks Technology

Telix Pharmaceuticals (ASX:TLX) Gets FDA Green Light to Resubmit — What Investors Should Know

Telix Pharmaceuticals Gains FDA Clarity on Glioma Imaging Agent Telix Pharmaceuticals (ASX: TLX) has given investors reason to sit up and take notice. The company announced it has reached agreement with the U.S. Food and Drug Administration on the resubmission of its new drug application for TLX101-CDx (Pixclara), an imaging agent designed for glioma. What…

ByCharlie YouldenSeptember 9, 20250Comments

Mining Stocks Small Caps Stocks

Brazilian Rare Earths (ASX: BRE): Early Moves in a Global Growth Market

Brazilian Rare Earths (ASX: BRE) – Final Permit Secures Path to Pilot Plant Operations Brazilian Rare Earths (ASX: BRE) has been one of the market’s standout movers, soaring 42% percent in the last 5 days after securing final approval for its rare earths pilot plant in Bahia. This green light from Brazil’s National Authority on…

ByCharlie YouldenSeptember 9, 20250Comments

Uncategorized

Why ClearVue Technologies (ASX: CPV) Just Sparked Fresh Investor Excitement

ClearVue Technologies – Gen3 Solar Vision Glass Breakthrough ClearVue Technologies (ASX: CPV) turned heads this week after its share price surged more than 20 percent on the back of a breakthrough announcement. The company revealed that its Gen3 Solar Vision Glass prototype has been independently validated by the Solar Energy Research Institute of Singapore, confirming…

ByCharlie YouldenSeptember 9, 20250Comments

Market news Tech Stocks Technology

Artificial Intelligence: Smart Strategies for Investors

How Investors Can Ride the Next Wave of AI Growth NVIDIA (NSDQ: NVDA) has become the face of the artificial intelligence boom, riding a wave of explosive growth as companies pour hundreds of billions of dollars into building the infrastructure behind AI. But for retail investors, the story is bigger than just one stock. AI…

ByCharlie YouldenSeptember 9, 20250Comments

Market news Uncategorized

How Independent is the US Federal Reserve in the Age of Trump?

The US Federal Reserve is under Pressure: Why Gold Is Beating Every Market Gold has always been seen as a safe haven, but its latest surge has left even seasoned investors asking questions. With prices climbing to US$3,560 and returns topping 42 percent, gold has outpaced nearly every major benchmark this year. The rally is…

ByCharlie YouldenSeptember 9, 20250Comments

Blue Chip Stocks Tech Stocks Uncategorized

Global X FANG+ ETF (ASX: FANG): A Simple Way to Ride the Next Wave of Big Tech

Why the Global X FANG+ ETF (ASX: FANG) Could Be a Growth Investor’s Shortcut to Innovation Global X FANG+ ETF (ASX: FANG) gives investors a front row seat to some of the most powerful companies driving global markets today. Instead of trying to handpick the next winner among Apple, Microsoft, NVIDIA, or Tesla, this ETF…

ByCharlie YouldenSeptember 3, 20250Comments

Healthcare Stocks Tech Stocks

Argenica Therapeutics (ASX: AGN): A 60% Crash or a Second Chance?

Argenica Therapeutics Just Faced Its Toughest Test — What Comes Next Argenica Therapeutics Ltd (ASX: AGN) has been thrown into the spotlight after its phase 2 trial results for ARG-007 sparked a brutal sell-off, sending the share price tumbling more than 60 percent in a single day. For investors, that kind of market reaction is…

ByCharlie YouldenSeptember 3, 20250Comments

Mining Stocks Small Caps Stocks Technology

Metallium (ASX: MTM) Lands First U.S. Defense Deal — Could This Be the Start of Something Big?

Metallium Breaks Into U.S. Defense Funding: A Small Contract with Big Implications Metallium (ASX: MTM) just landed its first U.S. Department of Defense contract, and while the value is only USD 100,000, the implications are far more significant. This Phase 1 Small Business Innovation Research award marks the company’s formal entry into the U.S. federal…

ByCharlie YouldenSeptember 2, 20250Comments

Small Caps Stocks Tech Stocks

Shares in Nanoveu (ASX: NVU) Surge 25% on AI Chip Milestone

Nanoveu Soars 25% on Drone Breakthrough Nanoveu (ASX: NVU) caught the market’s attention today with a 25 percent surge after its EMASS subsidiary announced a breakthrough in drone technology. At the heart of the news is the company’s ECS Dot Edge AI Chip, which has shown the ability to extend drone flight endurance by an…

ByCharlie YouldenSeptember 2, 20250Comments